The development of targeted medicine has greatly expanded treatment options and spurred
new research avenues in cancer therapeutics, with monoclonal antibodies (mAbs) emerging …

In spite of the successful use of monoclonal antibodies (mAbs) in clinic for tumor treatment,
their applications are still hampered in therapeutic development due to limitations, such as …

Photodynamic therapy (PDT) is a promising cancer treatment which involves a
photosensitizer (PS), light at a specific wavelength for PS activation and oxygen, which …

Nanobodies are antibody fragments derived from camelids, naturally endowed with
properties like low molecular weight, high affinity and low immunogenicity, which contribute …

Rationale A substantial number of breast cancer patients with an overexpression of the
human epidermal growth factor receptor 2 (HER2) have residual disease after neoadjuvant …

Introduction Monoclonal antibodies have revolutionized personalized medicine for cancer in
recent decades. Despite their broad application in oncology, their large size and complexity …

Nanoparticles (NPs) are commonly modified with tumor-targeting moieties that recognize
proteins overexpressed on the extracellular membrane to increase their specific interaction …

As a non‐invasive treatment modality, photodynamic therapy has been a potential
therapeutic method for metastatic and non‐metastatic tumors. In order to further improve the …

Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer treatment
modality based on a target-specific photosensitizer conjugate (TSPC) composed of an NIR …

Infections caused by multidrug-resistant Staphylococcus aureus, especially methicillin-
resistant S. aureus (MRSA), are responsible for high mortality and morbidity worldwide …